Neonatal Drug Therapy Manual

Budesonide

Disclaimer: Official controlled document is the CHEO and Ottawa Hospital online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Updated March 5, 2024 - 2:33pm

Alternate Name(s): 
Pulmicort
Classification: 
Adrenal Corticosteroid
Original Date: 
April 2010
Revised Date: 
Indications: 
  • Adjunctive treatment for BPD
Administration: 
  • Administer only with a compressed air driven jet nebulizer; do not use an ultrasonic nebulizer
Dosage: 
  • 0.25 - 0.5 mg twice daily
Side Effects: 
  • Endocrine and metabolic: the risk of clinically significant adrenal suppression with the use of budesonide is thought to be low but is increased with higher doses or with combined systemic and inhaled therapy
  • Local: nasal irritation, burning, growth of Candida in the mouth, throat or nares
  • Respiratory: cough, wheezing, brochospasm
Parameters to Monitor: 
  • Check mucous membranes for signs of fungal infection
Reconstitution and Stability: 

N/A

Compatibility: 

N/A

Notes: 
  • Avoid exposure of nebulized medication to eyes
References: 

The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.